PanTher Therapeutics
WATERTOWN, MA · Healthcare, Health Care · 9 employees
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. Our highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability
Funding history
- Series Seed — $3.0M — Apr 2025
- Series Seed — $2.7M — Dec 2023
- Series Seed — $1.3M — Dec 2022
- Series Seed — $1.1M — Jun 2022
- Series Series A — $5.4M — Jun 2021
Recent signals
- Apr 03, 2025: Raised $3.0M in Series Seed
- Dec 18, 2023: Raised $2.7M in Series Seed
- Dec 19, 2022: Raised $1.3M in Series Seed
- Jun 24, 2022: Raised $1.1M in Series Seed
- Jun 17, 2021: Raised $5.4M in Series Series A
- Jun 02, 2021: Raised $7.3M in Series Venture - Series Unknown
- Jun 04, 2020: Raised $3.0M in Series Seed
- May 18, 2020: Raised $209K in Series Pre-Seed
See plans & pricing → Track PanTher Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.